$3.73B
$5.74 Million
0.0% of portfolio
231,021
Q2 2025
New
$4.8B
$965,000
0.0% of portfolio
11,136
Q2 2025
Added 75.59%
$396M
$135,000
0.0% of portfolio
10,437
Q2 2025
New
$698M
$417,000
0.0% of portfolio
51,324
Q2 2025
Reduced 8.42%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 79.8%
$33.2B
$2.86 Million
0.0% of portfolio
16,522
Q2 2025
Reduced 41.24%
$3.32B
$752,000
0.0% of portfolio
3,412
Q2 2025
Added 88.3%
-
$0
0.0% of portfolio
-
Q2 2025
Added 130.24%
$605M
$1.28 Million
0.0% of portfolio
54,331
Q2 2025
Reduced 18.0%
-
$0
0.0% of portfolio
-
Q2 2025
Added 1,098.99%
$0
$584,000
0.0% of portfolio
6,556
Q2 2025
Added 65.81%
$0
$499,000
0.0% of portfolio
3,381
Q2 2025
Added 55.02%
$0
$1.21 Million
0.0% of portfolio
24,075
Q1 2025
Reduced 34.15%
$602M
$380,000
0.0% of portfolio
90,062
Q2 2025
Added 565.45%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.41%
$484M
$71,000
0.0% of portfolio
10,470
Q2 2025
Reduced 12.6%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 19.81%
$0
$0
0.0% of portfolio
57,449
Q2 2025
Added 69.98%
$326M
$104,000
0.0% of portfolio
10,929
Q2 2025
Reduced 55.75%
$293M
$609,000
0.0% of portfolio
18,149
Q2 2025
Reduced 28.69%
$3.21B
$3.06 Million
0.0% of portfolio
69,030
Q2 2025
Added 218.48%
Artius Ii Acquisition Inc
-
$0
0.0% of portfolio
-
Q2 2025
New
$5.18B
$214,000
0.0% of portfolio
900
Q2 2025
Reduced 98.67%
$10.9B
$1.24 Million
0.0% of portfolio
7,186
Q2 2025
Reduced 64.99%
$300M
$122,000
0.0% of portfolio
20,722
Q2 2025
Reduced 16.41%
Aspire Biopharma Hldgs Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
$3.72B
$4.65 Million
0.0% of portfolio
190,732
Q2 2025
Added 58.53%
$1.01B
$2.12 Million
0.0% of portfolio
50,776
Q2 2025
Reduced 59.24%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 39.86%
$101M
$441,000
0.0% of portfolio
82,396
Q2 2025
Added 339.28%
$167M
$198,000
0.0% of portfolio
20,361
Q1 2025
Added 24.85%
$685M
$1.52 Million
0.0% of portfolio
695,031
Q2 2025
Reduced 30.03%
$292M
$705,000
0.0% of portfolio
195,852
Q2 2025
Reduced 43.16%
$2.35B
$4.72 Million
0.0% of portfolio
66,855
Q2 2025
Reduced 61.15%
-
$0
0.0% of portfolio
-
Q2 2025
Added 75.95%
-
$0
0.0% of portfolio
-
Q2 2025
Added 26.35%
-
$0
0.0% of portfolio
-
Q2 2025
Added 320.51%
$23.2B
$5.03 Million
0.0% of portfolio
32,633
Q2 2025
Reduced 74.43%
Atmus Filtration Technologie
-
$0
0.0% of portfolio
-
Q2 2025
Added 5.69%
$88.8M
$1.72 Million
0.0% of portfolio
341,407
Q2 2025
Added 345.29%
-
$0
0.0% of portfolio
-
Q2 2025
Added 34.19%
$1.66B
$254,000
0.0% of portfolio
7,776
Q2 2025
Reduced 69.33%
-
$0
0.0% of portfolio
-
Q2 2025
Added 89.55%
$53.2M
$28,000
0.0% of portfolio
15,286
Q2 2025
New
$316M
$1.22 Million
0.0% of portfolio
124,424
Q2 2025
Reduced 26.76%
$1.61B
$2.89 Million
0.0% of portfolio
341,540
Q2 2025
Added 29.16%
$3.6B
$536,000
0.0% of portfolio
20,797
Q2 2025
New
$10.2B
$5.33 Million
0.0% of portfolio
26,856
Q2 2025
Reduced 48.35%
Avadel Pharmaceuticals PLC
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 11.55%
$8.53B
$297,000
0.0% of portfolio
22,068
Q2 2025
Reduced 91.56%